SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-178525
Filing Date
2015-05-08
Accepted
2015-05-08 09:01:22
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d901413d10q.htm 10-Q 288193
2 EX-31.1 d901413dex311.htm EX-31.1 9211
3 EX-31.2 d901413dex312.htm EX-31.2 9218
4 EX-32.1 d901413dex321.htm EX-32.1 4419
  Complete submission text file 0001193125-15-178525.txt   4003456

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ampe-20150331.xml EX-101.INS 462080
6 XBRL TAXONOMY EXTENSION SCHEMA ampe-20150331.xsd EX-101.SCH 46674
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20150331_cal.xml EX-101.CAL 46426
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ampe-20150331_def.xml EX-101.DEF 201854
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20150331_lab.xml EX-101.LAB 357707
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20150331_pre.xml EX-101.PRE 293374
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 15844632
SIC: 2834 Pharmaceutical Preparations